4.355
price up icon0.35%   0.025
 
loading
Precedente Chiudi:
$4.33
Aprire:
$4.4
Volume 24 ore:
405.87K
Relative Volume:
0.64
Capitalizzazione di mercato:
$363.76M
Reddito:
$70.14M
Utile/perdita netta:
$-76.24M
Rapporto P/E:
-5.1235
EPS:
-0.85
Flusso di cassa netto:
$-57.06M
1 W Prestazione:
+16.18%
1M Prestazione:
+32.07%
6M Prestazione:
+23.79%
1 anno Prestazione:
+126.30%
Intervallo 1D:
Value
$4.315
$4.525
Intervallo di 1 settimana:
Value
$3.70
$4.525
Portata 52W:
Value
$1.85
$4.91

Codexis Inc Stock (CDXS) Company Profile

Name
Nome
Codexis Inc
Name
Telefono
650-421-8100
Name
Indirizzo
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Name
Dipendente
174
Name
Cinguettio
@codexisinc
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
CDXS's Discussions on Twitter

Confronta CDXS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
CDXS 4.355 363.76M 70.14M -76.24M -57.06M -0.85
VRTX 450.27 115.43B 10.63B -479.80M -1.35B 13.33
REGN 748.65 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 590.61 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.57 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.17 24.89B 3.30B -501.07M 1.03B 11.54

Codexis Inc Stock (CDXS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-05-09 Downgrade H.C. Wainwright Buy → Neutral
2022-03-31 Ripresa Piper Sandler Overweight
2022-03-02 Ripresa Cowen Outperform
2021-04-12 Iniziato Piper Sandler Overweight
2021-03-01 Iniziato Stifel Buy
2021-02-26 Reiterato H.C. Wainwright Buy
2020-03-10 Iniziato The Benchmark Company Buy
2019-01-17 Aggiornamento First Analysis Sec Neutral → Outperform
2018-05-16 Iniziato Stephens Overweight
2017-10-13 Reiterato H.C. Wainwright Buy
2017-05-31 Iniziato Jefferies Buy
2017-01-26 Downgrade First Analysis Sec Overweight → Equal-Weight
2017-01-04 Aggiornamento Ladenburg Thalmann Neutral → Buy
2016-01-06 Iniziato H.C. Wainwright Buy
Mostra tutto

Codexis Inc Borsa (CDXS) Ultime notizie

pulisher
12:22 PM

Codexis (STU:4QK) 3-Year FCF Growth Rate : -35.00% (As of Sep. 2024) - GuruFocus.com

12:22 PM
pulisher
Nov 20, 2024

Codexis (STU:4QK) Forward Dividend Yield % : 0.00% (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire

Nov 20, 2024
pulisher
Nov 19, 2024

Codexis to Present at Piper Sandler Healthcare Conference in December 2024 | CDXS Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 15, 2024

Codexis (NASDAQ:CDXS) Given Overweight Rating at Cantor Fitzgerald - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Codexis Achieves 98% Efficiency in Breakthrough siRNA Synthesis Platform | CDXS Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

Baillie Gifford & Co. Sells 895,002 Shares of Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Nov 14, 2024
pulisher
Nov 12, 2024

Codexis adds biotech veteran Raymond De Vré to board - Investing.com India

Nov 12, 2024
pulisher
Nov 12, 2024

Codexis Strengthens Board and Updates Bylaws - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

CDXSCodexis, Inc. Latest Stock News & Market Updates - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Codexis adds biotech veteran Raymond De Vré to board By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 12, 2024

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Codexis Strengthens Board with Biotech Veteran Raymond De Vré, Former PolyPeptide CEO | CDXS Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Biofuel Enzymes Market Growth Surge: Key Players and Market - openPR

Nov 12, 2024
pulisher
Nov 11, 2024

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics - GlobeNewswire

Nov 11, 2024
pulisher
Nov 11, 2024

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for - The Bakersfield Californian

Nov 11, 2024
pulisher
Nov 11, 2024

Codexis to Showcase Breakthrough RNA Platform, Partners with Bachem at TIDES Europe 2024 | CDXS Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 08, 2024

Codexis Announces New Employment Inducement Grants - The Manila Times

Nov 08, 2024
pulisher
Nov 07, 2024

Codexis, Inc.'s (NASDAQ:CDXS) 29% Jump Shows Its Popularity With Investors - Simply Wall St

Nov 07, 2024
pulisher
Nov 06, 2024

Benchmark Downgrades Codexis (CDXS) - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

CDXS (Codexis) PE Ratio : At Loss (As of Nov. 06, 2024) - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Codexis (FRA:4QK) 3-Year EBITDA Growth Rate : -26.40% (As of Sep. 2024) - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Benchmark Reaffirms “Hold” Rating for Codexis (NASDAQ:CDXS) - Defense World

Nov 06, 2024
pulisher
Nov 06, 2024

Codexis's SWOT analysis: enzyme engineering firm pivots to RNAi stock By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

abrdn plc Grows Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

Codexis's SWOT analysis: enzyme engineering firm pivots to RNAi stock - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

Codexis to Participate in Upcoming Healthcare Conferences - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Codexis (NASDAQ:CDXS) Earns Hold Rating from Benchmark - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17 - Yahoo Finance

Nov 03, 2024
pulisher
Nov 03, 2024

Codexis, Inc. Announces Strong Third Quarter 2024 Financial Results - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Codexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Nov 02, 2024
pulisher
Nov 02, 2024

Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Codexis, Inc. (NASDAQ:CDXS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 02, 2024
pulisher
Nov 01, 2024

Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings call: Codexis reports revenue growth and strategic focus in Q3 2024 - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Codexis Inc Q3 2024 Earnings: Revenue Hits $12.83M, Beating Esti - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus ... - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Codexis Reports Strong Q3 Revenue Growth - TipRanks

Nov 01, 2024
pulisher
Oct 31, 2024

Codexis: Q3 Earnings Snapshot - CT Insider

Oct 31, 2024
pulisher
Oct 31, 2024

Codexis Reports Third Quarter 2024 Financial Results - The Manila Times

Oct 31, 2024

Codexis Inc Azioni (CDXS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):